Human Palmitoyl-Protein Thioesterase 1 (PPT1) Protein

Product Graph
273€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Palmitoyl-Protein Thioesterase 1 (PPT1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx690425
tested applications
SDS-PAGE

Description

Palmitoyl-Protein Thioesterase 1 (PPT1) protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Palmitoyl-Protein Thioesterase 1 (PPT1)
Host
HEK293 cells
Assay Type
Activity: Not tested
Sequence Fragment: Asp28-Gly306
Tag: C-terminal 6 His tag
Origin
Human
Observed MW
Calculated MW: 32.3 kDa  Observed MW (SDS-PAGE): 34-41 kDa
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Purification
0.2 µm filtered.
Size 1
10 µg
Size 2
50 µg
Form
Liquid
Tested Applications
SDS-PAGE
Buffer
20 mM Tris-HCl, 150 mM NaCl, pH 7.4 containing 10% Glycerol.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Shelf Life: 6 months.
Dry Ice
No
UniProt ID
P50897
Gene ID
5538
OMIM
256730, 600722
Background
Protein PPT1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

Related Products

FNab06739

PPT1 antibody

Removes thioester-linked fatty acyl groups such as palmitate from modified cysteine residues in proteins or peptides during lysosomal degradation. Prefers acyl chain lengths of 14 to 18 carbons.

Ver Producto
Pr22704

Recombinant Human PPT1

Ver Producto
abx031626

Palmitoyl-Protein Thioesterase 1 (PPT1) Antibody

Palmitoyl-protein thioesterase-1 (PPT1) is a lysosomal hydrolase that removes long-chain fatty acyl groups from modified cysteine residues in proteins. Mutations in PPT1 have been found to cause the infantile form of neuronal ceroid lipofuscinosis (INCL), and an animal model has been developed.1 The deduced PPT2 protein contains 302 amino acids, including a 27-amino acid leader peptide, a sequence motif characteristic of many thioesterases and lipases, and 5 potential N-linked glycosylation sites.2 PPT2 shares 18% amino acid identity with PPT1. Northern blot analysis detected a predominant 2.0-kb PPT2 transcript in the human tissues examined, with the highest expression in skeletal muscle; variable amounts of 2.8 and 7.0-kb transcripts were also observed. Recombinant PPT2, like PPT1, possesses thioesterase activity and localizes to the lysosome. Since PPT2 could not substitute for PPT1 in correcting the metabolic defect in INCL cells and was unable to remove palmitate groups from palmitoylated proteins that are routinely used as substrates for PPT1it has been postulated that PPT2 possesses a different substrate specificity than PPT1.

Ver Producto